Personalization of radiotherapy through the development of mathematical models of molecular (e.g., water, oxygen, chemotherapy drugs, contrast agents) transport in tumours to bridge the gap between “micro-scale” phenomena—tumour hypoxia, vascular architecture, stromal cell/endothelial cell distributions—and macroscopic-scale imaging (e.g., MRI, CT, PET).
Edward Taylor, MSc, PhD
Clinician Investigator, Princess Margaret Cancer Centre
Clinician Investigator, Princess Margaret Cancer Centre
Medical Physicist, Radiation Medicine Program, Princess Margaret Cancer Centre
Assistant Professor, Department of Radiation Oncology, University of Toronto